2014

Welcome to Volume 13, Issue #5 (May 2014) of Pharma Marketing News.

According to the latest Cegedim Strategic Data (CSD) Audit, the 20 pharma companies that spent the most on total promotion -- which includes traditional professional detailing, eDetailing, Direct-to-Consumer (DTC) advertising, professional meetings, and journal advertising -- spent a total of $14,784 Bn in 2013. This article analyzes data from several sources to determine how much of this is allocated to various media and channels and also looks at the trends for several channels.

'The medical conference is dead, long live the medical conference,' is the title of a SlideShare presentation by Len Starnes (@lenstarnes), a respected digital health-care consultant. Starnes is referring to the emergence of the 'virtual' medical conference, which he believes will soon be adopted in one form or another by all medical societies. This article describes the changes occurring viz-a-viz major medical conferences and the impact this will have on the pharmaceutical industry, medical societies, healthcare professionals, and patients.

Welcome to Volume 13, Issue #4 (April 2014) of Pharma Marketing News.

The comments are in! As usual, the pharma industry waited until the last minute to submit comments to FDA Docket 2013-N-1430 regarding recent FDA social media draft guidance. This article provides highlights from submissions by Novartis, Shire, the Pharmaceutical Research and Manufacturers of America (PhRMA), the Biotechnology Industry Organization (BIO), Klick Health, the Social Media Compliance Council (SMCC), the Coalition for Healthcare Communication (CHC), and the Digital Health Coalition (DHC), and other interested parties.

This article focuses on a few of the issues, gray areas, and questions mentioned during the 'Green light or go slow' webcast and also in comments submitted to the FDA.

Welcome to Volume 13, Issue #3 (March 2014) of Pharma Marketing News.

This article discusses both the right and wrongs ways for pharma to edit Wikipedia articles about its products using real-life examples.

A growing number of doctors prefer digital communications and the pharmaceutical industry is currently in the process of moving its sales force to a smaller structure that is more directly aligned with this new reality. One aspect of that change is the deployment of

Back in June, 2011, Pharmaguy published the first iteration (Volume One) of the Pharmaguy Social Media Timelime™. Since then there have been many noteworthy pharma social media events, trials, and tribulations that deserve to be added to the Timeline. Volume Two includes 23 new items/events from June, 2011 through January, 2014.